Ophthalmic Devices - Algeria

  • Algeria
  • The projected revenue in the Ophthalmic Devices market market in Algeria is estimated to reach US$124.20m by the year 2024.
  • It is expected to exhibit a compound annual growth rate (CAGR 2024-2029) of 3.86%, leading to a market volume of US$150.10m by 2029.
  • When compared globally, the United States is anticipated to generate the highest revenue, amounting to US$14,000.00m in 2024.
  • Algeria's ophthalmic devices market is witnessing a surge in demand due to increasing prevalence of eye disorders and the government's focus on improving healthcare infrastructure.

Key regions: Germany, Italy, France, Japan, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Ophthalmic Devices market in Algeria is experiencing steady growth due to increasing customer preferences for advanced eye care solutions, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers in Algeria are increasingly demanding advanced ophthalmic devices to address various eye conditions. This is driven by a growing awareness about eye health and the availability of innovative technologies in the market. Algerian consumers are seeking ophthalmic devices that offer accurate diagnosis, effective treatment, and improved visual outcomes. They are also showing a preference for devices that are easy to use, portable, and affordable.

Trends in the market:
One of the key trends in the Ophthalmic Devices market in Algeria is the adoption of advanced diagnostic devices such as optical coherence tomography (OCT) and fundus cameras. These devices provide high-resolution images of the eye, enabling early detection and diagnosis of various eye conditions including glaucoma, macular degeneration, and diabetic retinopathy. The increasing prevalence of these eye conditions in Algeria is driving the demand for such advanced diagnostic devices. Another trend in the market is the growing popularity of refractive surgery, particularly LASIK (laser-assisted in situ keratomileusis). LASIK is a surgical procedure that corrects refractive errors such as nearsightedness, farsightedness, and astigmatism. The demand for LASIK procedures is increasing in Algeria as it offers a permanent solution to vision problems and eliminates the need for glasses or contact lenses.

Local special circumstances:
Algeria has a high prevalence of eye diseases and vision problems, which is driving the demand for ophthalmic devices. Factors such as aging population, increasing prevalence of diabetes, and exposure to environmental factors contribute to the high incidence of eye diseases in the country. The government of Algeria has recognized the importance of addressing these eye health issues and has been implementing various initiatives to improve access to quality eye care services and ophthalmic devices.

Underlying macroeconomic factors:
Algeria is experiencing economic growth, which is positively impacting the Ophthalmic Devices market. The rising disposable income of the population is enabling more people to afford ophthalmic devices and eye care services. Additionally, the government's focus on healthcare infrastructure development and increasing healthcare expenditure is creating a favorable environment for the growth of the Ophthalmic Devices market in Algeria. In conclusion, the Ophthalmic Devices market in Algeria is witnessing growth due to increasing customer preferences for advanced eye care solutions, adoption of advanced diagnostic devices, growing popularity of refractive surgery, high prevalence of eye diseases, and favorable macroeconomic factors. The market is expected to continue its growth trajectory in the coming years as the demand for ophthalmic devices and eye care services continues to rise in Algeria.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)